CIDEC
Lipid transferase CIDEC
Also known as: CIDE-3, CIDEC_HUMAN, FLJ20871, Fsp27
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96AQ7
- Gene
- CIDEC
- Ensembl
- ENSG00000187288
- Chromosome
- 3
- Canonical length
- 238 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of the cell death-inducing DNA fragmentation factor-like effector family. Members of this family play important roles in apoptosis. The encoded protein promotes lipid droplet formation in adipocytes and may mediate adipocyte apoptosis. This gene is regulated by insulin and its expression is positively correlated with insulin sensitivity. Mutations in this gene may contribute to insulin resistant diabetes. A pseudogene of this gene is located on the short arm of chromosome 3. Alternatively spliced transcript variants that encode different isoforms have been observed for this gene. [provided by RefSeq, Dec 2010]
Canonical amino-acid sequenceUniProt
238 residues, UniProt reviewed canonical sequence.
>Q96AQ7|CIDEC
1 MEYAMKSLSL LYPKSLSRHV SVRTSVVTQQ LLSEPSPKAP RARPCRVSTA DRSVRKGIMA
61 YSLEDLLLKV RDTLMLADKP FFLVLEEDGT TVETEEYFQA LAGDTVFMVL QKGQKWQPPS
121 EQGTRHPLSL SHKPAKKIDV ARVTFDLYKL NPQDFIGCLN VKATFYDTYS LSYDLHCCGA
181 KRIMKEAFRW ALFSMQATGH VLLGTSCYLQ QLLDATEEGQ PPKGKASSLI PTCLKILQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CIDEC can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 704 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 704 nTPM
- breast: 500 nTPM
- small intestine: 85 nTPM
- blood vessel: 77 nTPM
- duodenum: 65 nTPM
- skin: 19 nTPM
Single-cell type
- enterocytes: 322 nCPM
- adipocytes: 197 nCPM
- colonocytes: 32 nCPM
- foveolar cells: 30 nCPM
- fibroblasts: 8.2 nCPM
- paneth cells: 7.7 nCPM
Immune cell
- memory B-cell: 0.4 nTPM
- plasmacytoid DC: 0.3 nTPM
- myeloid DC: 0.1 nTPM
- naive B-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
Brain region
- basal ganglia: 0.6 nTPM
- pons: 0.6 nTPM
- cerebral cortex: 0.5 nTPM
- thalamus: 0.5 nTPM
- white matter: 0.5 nTPM
- amygdala: 0.4 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CIDEC.
Disease | AllUniProt
Conditions CIDEC is implicated in, by any mechanism.
- Lipodystrophy, familial partial, 5 (FPLD5) MIM:615238
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 77 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- CIDEC-related familial partial lipodystrophy
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.94
- gnomAD pLI
- 0.01
- gnomAD missense Z
- -0.67
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- execution phase of apoptosis
- lipid droplet fusion
- lipid droplet organization
- lipid storage
- negative regulation of lipid catabolic process
- negative regulation of triglyceride metabolic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CIDEC in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CIDEC as an antibody target. Whether an autoantibody or antibody against CIDEC could matter depends on whether native CIDEC is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CIDEC is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CIDEC as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...